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Abstract 
The role of low IV, phosphotyrosine protein phosphatase (PTPase) in the control of cell proliferation was studied. A synthetic gene coding for 
PTPase was transfected and expressed in NIH/3T3 fibroblasts. The effects of the enzyme were particularly evident when cells were stimulated by 
platelet-derived growth factor (PDGF). The mitogenic response to PDGF was decreased and the inhibition reached 90%. This effect was more 
pronounced with respect o fetal calf serum stimulation. Hormone-dependent autophosphorylation of the PDGF receptor was significantly reduced. 
These results demonstrate that low M, PTPase, a cytosolic enzyme, not only affects cellular response to PDGF but also reduces the membrane receptor 
autophosphorylation. 
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1. Introduction 
The phosphorylation of specific tyrosine residues of 
cellular proteins is a crucial event in the regulation of the 
cell cycle and proliferation [1,2]. An important family of 
growth factor receptors and oncogene products pos- 
sesses a tyrosine kinase activity leading to the phospho- 
rylation of receptors themselves as well as of several 
intracellular proteins. The phosphotyrosine level is de- 
termined by a finely regulated equilibrium between tyro- 
sine kinase and phosphatase activity and several differ- 
ent phosphotyrosine protein phosphatases (PTPases) 
seem to have a role in the modulation and/or in the 
counter regulation of growth factor-dependent tyrosine 
kinase activity during signal transduction [3]. Often 
PTPases may inhibit cell growth functioning as potential 
antioncogenes [4]. 
Molecular analysis of the PTPases has resulted in the 
identification of a common homology domain contain- 
ing a cysteine residue that is located in the active site and 
absolutely required for enzyme activity. This motif is 
common to the non-receptor cytosolic as well as to the 
receptor-like transmembrane PTPases [5-71. 
In spite of numerous studies, a very limited number of 
cellular substrates of PTPases has been clearly identified 
and few data confirm the in vivo interaction between 
PTPases and phosphoproteins implicated in signalling 
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pathways. For example, studies have indicated that the 
PTPase cdc25 causes the dephosphorylation of ~34”*“~, 
a serine/threonine kinase, triggering the onset of cell mi- 
tosis [8]. 
Indirect confirmations of the hypothesis about the role 
of PTPase in affecting cell growth arise from the effects 
of molecules such as vanadate and phenylarsine oxide, 
which are specific inhibitors of phosphotyrosine 
phosphatases [9-111. Inhibitors are able to amplify re- 
ceptor-dependent tyrosine phosphorylation and to pro- 
duce all the events linked to this kinase activity. 
Growth factors, like platelet-derived growth factor 
(PDGF), induce different events upon binding to their 
surface receptor. Some of these, as mentioned above, are 
connected to receptor autophosphorylation on several 
tyrosine residues. A function of the autophosphoryla- 
tion, at least in the case of PDGF receptor, seems to be 
the creation of binding sites available for several proteins 
characterised in their sequence by Src homology do- 
mains. Among these we can include the phospholipase 
Cy [12,13], the 85 kDa polypeptide subunit (~85) of 
phosphatidylinositol-3-kinase [ 14,151, the c-raf serine/ 
threonine kinase [ 161, members of the src family [ 171 and 
GTPase activating protein of ras [18]. Receptor auto- 
phosphorylation is a main event for this protein recruit- 
mentandprobablyfor developing total mitogenic activity. 
Results obtained by the expression of a T cell-derived 
intracellular PTPase in baby hamster cells [19], suggest 
that a cytosolic PTPase may not directly interact with 
growth factor tyrosine kinases. More recently it has been 
demonstrated that transfection of the transmembrane 
PTPase CD45 into Cl27 cells decreases PDGF and IGF- 
l-dependent receptor phosphorylation [20,21] and inhib- 
its hormone-dependent phosphatidylinositol-3-kinase 
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activation, tyrosine phosphorylation of protein sub- 
strates and their association to the receptor, but it does 
not affect the tyrosine phosphorylation of cytosolic pro- 
teins that are not substrates of the growth factor recep- 
tors. These data support the hypothesis that cellular lo- 
calization makes more logical the interaction between 
autophosphorylated receptors and those PTPases which 
possess a domain closely associated with cellular mem- 
brane. This type of PTPases could possess a specific role 
in the regulation of receptor signal transduction. 
Recently, we have shown the effects of the overexpres- 
sion of the low M, PTPase in tumoral cell lines [22,23]. 
This enzyme actively dephosphorylates phosphoty- 
rosine-containing proteins and peptides [24], and belongs 
to the non-receptor-like subfamily. The reaction mecha- 
nism involves the formation of a cysteinylphosphate in- 
termediate and the enzyme has the signature [25] of 
members of the PTPase family in its active site. 
The low M, PTPase dephosphorylates the tyrosine- 
autophosphorylated epidermal growth factor receptor in 
vitro [26] and inhibits the growth of NIH/3T3 cells trans- 
formedbyv-erbB[22]andbyotherdifferentoncogenes[23]. 
In this study, the effects of the overexpression of the 
low M, PTPase in murine NIH/3T3 fibroblasts on cell 
growth and tyrosine phosphorylation are investigated. 
Particularly we demonstrate that the low M, PTPase, a 
cytosolic PTPase, inhibits the cellular response to 




Human recombinant PDGF-BB was from Calbiochem. RCZO-per- 
oxidase conjugated antibodies to phosphotyrosine were from 
Transduction Laboratories (Lexington, KY). All other reagents were 
from Sigma en were of the highest quality available. 
2.2. Cell culture and transfection 
Parent NIH/3T3 murine fibroblasts were routinely cultured at low 
density in a humidified atmosphere of 5% COJ95% oxygen at 37°C in 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf 
serum (complete medium). Cells were transfected with pSVPTP plas- 
mid, containing a synthetic DNA sequence coding for low M, PTPase 
[271 under the control of the SV40 early region promoter, together with 
pKOneo, expressing neomycin (G418) resistance, using the calcium 
phosphate precipitation method as previously described [22]. Selection 
of stable G418-resistant clones was performed by supplementing the 
medium with 400 &ml of antibiotic. Neomycin resistant subclones 
were isolated and periodically grown in selective medium to maintain 
a stable expression. 
2.3. Evaluation of PTPase overexpression 
Northern blot analysis was done on total RNA under standard con- 
ditions, according to Ramponi et al. [22]. Hybridization, using the 
“P-1abelled PTPase synthetic gene as a probe, was performed under 
high stringency conditions (2 x SET at 65°C). 
The total content of PTPase in transfected cells was determined by 
a non-competitive immunoenzymatic assay. Antibodies to the recombi- 
nant enzyme were purified by affinity chromatography from rabbit 
antisera and coniugated to horseradish peroxidase. Microtiter polysty- 
rene wells coated with purified antibodies were chosen as solid phase. 
Using a standard solution of recombinant PTPase, the lower limit of 
quantitation was 0.1 ng/ml and linearity was kept up to 2 &ml. In this 
range there were negligible effects of lysate dilutions on the assay, 
observed using lysates depleted of the PTPase by immunoadsorption. 
The activity of the overexpressed enzyme in cell lysates was checked 
using p-nitrophenyl-phosphate as substrate. We measured the phos- 
phatase activity in the presence of vanadate to evaluate its inhibited 
portion. The rise of substrate hydrolysis was compared to the quantita- 
tive increase of the enzyme by assuming the specific activity of the 
purified enzyme [28]. 
The level of enzyme xpression remained approximately the same for 
up to two months. 
2.4. Hormone stimulation of cells 
Subconlhtent 35-mm dishes of control and PTPase overexpressing 
cells were starved for 24 h in serum-free medium. Medium was then 
changed and a serum-free medium containing PDGF-BB was added to 
the cells. After a 5 min hormone treatment, dishes were placed on ice, 
cells were washed twice with ice-cold phosphate-buffered saline (PBS) 
at pH 7.4, then they were harvested in PBS/EDTA 5 mM, centrifuged 
and the pellet was boiled in 100 ~1 of 1 x Laemmli sample buffer. 
2.5. Gel electrophoresis and immunoblotting 
Whole cells extracts were subjected to SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) on an 8% gel and then electrotransferred to
nitrocellulose membrane (Sartorius). The membrane was blocked with 
1% bovine serum albumin in Tris-buffered saline (TBS) (25 mM Tris, 
pH 7.4, 137 mM NaC1, 0.1% Tween) for 60 min and incubated with 
RC20 anti-phosphotyrosine antibody HRP-conjugated for 70 min at 
25°C. The membrane was then extensively washed with TBS and the 
immunoreactive proteins were visualized by enhanced chemilumines- 
cence (ECL) (Amersham) detection following the manufacturer’s in- 
structions. 
2.6. Mitogenic response in PTPase-positive cells and controls 
PTPase-positive cells and controls were serum starved for 24 h. Fetal 
calf serum (FCS) (10% final), or PDGF-BB, were added with a change 
of media and the cells were allowed to grow for an additional 20 h. They 
were then labelled with 1 ,&i/ml of [‘Hlthymidine for4 h, washed once 
with 10% trichloroacetic acid, twice with PBS and solubilized in 0.2 N 
NaOH. This lysate was used to quantitate protein concentration and 
incorporation of label into DNA by liquid scintillation counting. 
2.7. Membrane preparation 
Cells were washed in PBS, scraped from culture dishes, and collected 
by centrifugation. Cells were then resuspended in lysis buffer (20 mM 
HEPES, pH 7.4, 0.1 mM EDTA, 1 mM MgCl,, 1 mM dithiothreitol, 
0.1 mM benzamidine and 2 mM phenylmethanesulphonyl fluoride) and 
disrupted by Dounce homogenization. The homogenate was clarified 
at 300 x g for 10 min and centrifuged at 2000 x g for 15 min to remove 
nuclei and then the supernatant was newly centrifuged at 100,000 x g 
for 30 min at 4°C. The supernatant fraction (SlOO) was adjusted to 1% 
Triton. The pellet (PlOO) was rinsed in 1 ml of phosphate-buffered 
saline and then solubilized in lysis buffer containing 1% Triton. Protein 
concentration and PTPase content were determined respectively by 
Bradford’s method [29] and ELISA in SlOO and PlOO fractions. 
2.8. PTPase inhibitors 
The stock solutions of sodium orthovanadate were prepared as de- 
scribed previously [30]. Phenylarsine oxide (PAO) was dissolved in 
dimethylsulphoxide. Cells were treated with 20pM PA0 for 30 min and 
with 2 mM vanadate for 10 min before growth factor stimulation. 
3. Results and discussion 
cDNAs coding for low A4, PTPase and neomycin-re- 
sistance were transfected in NIH/3T3 murine fibroblasts. 
From resistant cells we isolated many clones some of 
which were selected for the analysis of low M, PTPase 
expression at both mRNA and protein level. The levels 
of PTPase mRNA were determined by Northern blot 
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analysis of total cellular RNA. A non-competitive 
ELISA using affinity-purified antibodies was used to 
quantitatively determine the low M, PTPase protein ex- 
pression in whole cell extracts. In low J4, PTPase trans- 
fected subclones, the level of the expressed enzyme was 
in agreement with the Northern blot analysis. The in- 
crease in vanadate-sensitive phosphatase activity, meas- 
ured in cell extracts using p-nitrophenyl-phosphate as 
substrate, gave results completely comparable to the 
quantitative determination of the enzyme by ELISA, by 
relating experimental data on the basis of the specific 
activity of the purified PTPase. Therefore the transfected 
gene product was demonstrated to be the active PTPase. 
The subclones, which maintained a stable low M, 
PTPase expression by periodical exposure to G4 18, were 
used for our studies. These cells expressed the enzyme 
about lo-fold over the levels of controls. Interestingly, 
no subclone showing an overexpression of the enzyme 
higher than this was found, contrary to what happened 
using NIH/3T3 fibroblasts transformed by various onco- 
genes in transfection experiments [20,2 11. This observa- 
tion suggests that in our case the absence of an oncogene 
product such as, for instance, a highly active tyrosine 
kinase, might not have allowed PTPase overexpression 
at levels that were cytotoxic to the NIH/3T3 normal cells. 
increased progressively as the cells reached confluence 
and arrested their growth (Fig. 1). Its quantity ranged 
approximately from 12 to 77 ng/mg of proteins. After the 
confluence, the PTPase level became lower, probably as 
a consequence of cell suffering. This behaviour is com- 
mon to other PTPases [31] and it is peculiar to enzymes 
which counteract he mitogenic signal. 
The constitutive expression of the low A4, PTPase in 
neomycin-resistant control clones depended on the rate 
of proliferation. We observed that the level of the enzyme 
The overexpression of the low M, PTPase affected the 
mitogenic potential of PDGF. This growth factor was an 
effective mitogen in the NIH/3T3 cell line, giving rise to 
a response, calculated as [3H]thymidine incorporation, 
similar to 10% FCS. When the cells were grown in a 
complete medium permanently supplemented with 10% 
FCS, the effects of PTPase overexpression were mild. 
The clones grew somewhat more slowly than comparable 
cells transfected only with the pKOneo plasmid. How- 
ever, the ability of PTPase transfected cells to recover 
from serum starvation was significantly lower (73% inhi- 
bition), as appeared from the [3H]thymidine incorpora- 
tion under serum stimulation after 24 h serum starvation 
(Fig. 2). Moreover, when cells were starved and then 
stimulated with PDGF-BB, the effect, due to the pres- 
ence of higher levels of expressed enzyme, was extremely 
significant. The inhibition of PDGF-BB induced [3H]thy- 
midine incorporation in cells overexpressing PTPase 
compared to the untransfected ones reached 90% (Fig. 
2). 
From these data it was evident that clones overex- 
PTPase levels in NIHBT3 at various cell density 
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Fig. 1. Level of endogenous low M, PTPase in NIW3T3 fibroblasts. Cells were grown at various final density in complete medium in 60-mm dishes, 
washed twice with PBS and then harvested in 300 ~1 of lysis buffer (50 mM MES, 1 mM EDTA, pH 6.8, 1.5 mM phenylmethanesulphonyl fluoride, 
0.1 mM benxamidine, 0.1 mM DIT). After sonication an aliquot was taken for total protein determination. PTPase levels were determined on the 
lysate by a sandwich ELISA using a polyclonal antibody raised against low M, PTPase, then normalized for protein concentration of the lysate. The 
PTPase content is related to the total protein concentration of the lysate taken as a measure of cell density in the dish. Results are mean values of 
3 independent experiments. 
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Thymidine incorporation after 24 h serum starvation 
followed by 24 h of serum or PDGF stimulation 
24h+FCS 24 h + PDGF 
Fig. 2. [‘H]Thymidine incorporation in control and low M, PTPase overexpressing NIH13T3. Cells were serum-starved for 24 h, after which the basal 
level of [‘Hlthymidine incorporation was measured by a pulse (4 h) labelling. Starved cells were then stimulated with 10% FCS or 20 ng/ml PDGF-BB 
for 24 h, and [‘Hlthymidine incorporation was again measured. Values of incorporation are normalized for protein concentration and are reported 
as increase above the basal level. Data are obtained as means + S.E.M. (n = 4) of one experiment representative of 3 that gave qualitatively identical 
results. 
pressing the enzyme showed an impaired mitogenic re- 
sponse to PDGF-BB maximal stimulation. Such a dras- 
tic effect was not so evident when the cells were fed in the 
presence of FCS because in this case they were induced 
to proliferate by a lot of different stimuli. We could thus 
conclude that among the mitogenic factors present in 
FCS there are some whose action is not affected or less 
affected by the expression of the low M, PTPase. 
In order to assess the level of the signal cascade at 
which the antagonism to the mitogenic potential of the 
growth factor was effective, we examined the growth 
factor-dependent yrosine phosphorylation pattern in 
low M, PTPase transfected and normal cells. The overex- 
pression of the low iL& PTPase actually modified the 
PDGF-BB-dependent tyrosine phosphorylation in intact 
cells. In NIH/3T3 control cells the PDGF-BB produced 
increased phosphorylation of many proteins, the major 
one being the 180 kDa PDGF receptor. Other proteins 
appeared to be phosphorylated on tyrosine residues in 
response to PDGF-BB in a directly proportional meas- 
ure to the receptor itself. In low M, PTPase overex- 
pressing cells, the phosphorylation of the receptor band 
was significantly diminished at all the PDGF-BB concen- 
trations used (see Fig. 3). Beyond this, other proteins 
that were phosphorylated in response to PDGF stimula- 
tion seemed to diminish their phosphotyrosine content. 
Considering the molecular weight, one could connect 
them with the PDGF receptor substrates presently 
known and argue their potential identity. So a 140-kDa 
protein was similar in size to phospholipase Cy and a 
85kDa one was probably the phosphatidylinositol-3- 
kinase major subunit. All these proteins possess 
phosphotyrosine residues in their sequence and are 
known to form a complex with the autophosphorylated 
PDGF receptor by their src homology domains. More 
detailed studies will be needed to ascertain the actuality 
of these observations which point to a downstream effect 
of the diminished PDGF receptor phosphorylation. 
The observed decrease in tyrosine phosphorylation in 
response to PDGF was not produced by a smaller 
1 2 3 4 5 6 7 8 
control I PTPase+ 
Fig. 3. Tyrosine phosphorylation pattern in control and low M, PTPase 
overexpressing NIH/3T3 under PDGF-BB stimulation. After SDS-pol- 
yacrylamide gel electrophoresis, cell lysates were blotted, incubated 
with RC20-peroxidase conjugated antibodies to phosphotyrosine and 
detected by ECL. Cells were grown to subconfluence in 35-mm dishes 
and then serum-starved for 24 h. At the end of this period they were 
stimulated with different doses of PDGF-BB for 5 min. Lanes l- 
4 = control NIH/3T3; lanes 558 = PTPase NIH/3T3. Lanes 1 and 
5 = unstimulated; lanes 2 and 6 = 2 ng/ml PDGF; lanes 3 and 7 = 10 
&ml; lanes 4 and 8 = 40 ng/ml. 
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amount of specific receptor present in PTPase-positive 
cells or by a decrease in its constitutive kinase activity. 
PTPase inhibitors, like vanadate and phenylarsine oxide, 
were used to verify the integrity of the receptor in 
PTPase-positive and control cells. By inhibiting the 
phosphotyrosine phosphatase activity, we found an ex- 
tremely high tyrosine kinase activity and a similar extent 
of protein phosphorylation in PTPase-positive and con- 
trol cell lysates (Fig. 4). When cells were pretreated for 
10 min with 2 mM vanadate and 20 PM PA0 for 30 min, 
the phosphotyrosine content in many unidentified pro- 
teins increased several-fold over the level seen in un- 
treated cells. This effect was evident, with very few differ- 
ences, both in PDGF-stimulated and unstimulated cells. 
The basal level of PDGF receptor autophosphorylation, 
excluding the direct role of phosphatases in the down- 
regulation, seemed to reach the saturation of available 
sites [20,21,32]. In addition, the PDGF receptor has been 
partially purified using wheat germ agglutinin linked to 
a matrix and autophosphorylated by stimulating with 
PDGF-BB in vitro. The level of autophosphorylation 
was almost the same in the receptor isolated from 
PTPase-positive and control cells (results not shown), 
thus confirming the presence of an equal amount of ac- 
tive PDGF receptors in both cases. 
Logical inferences and several authors [19-211, who 
suggested that cytosolic PTPases may not interact with 
growth factor receptors, prompted us to consider more 
critically these results showing the possibility of an inter- 
action between the enzyme and the cellular membrane. 
The analysis of the molecular structure of the enzyme 
[33] had not revealed a C-terminus hydrophobic domain 
and no chemical derivatizations allowing association 
with the particulate fractions of the cells were found. 
Nevertheless, cell lysates from control and overex- 
pressing cells were prepared to examine the subcellular 
distribution of the overexpressed, as well as the en- 
dogenous PTPase. Cytosolic (SlOO) and membrane frac- 
tions (PlOO), obtained by high speed centrifugation, were 
checked for enzyme content by ELISA. More than 93% 
of the PTPase was present in the SlOO of control and 
overexpressing cells. Similar results were obtained when 
cells were stimulated with PDGF-BB before the subcellu- 
lar fractionation. Therefore, the localization of PTPase 
was not altered by the level of expression, and the distri- 
bution was not changed by growth factor stimulation. 
The demonstrated activity of this PTPase on the auto- 
phosphorylated EGF receptor in vitro [26], together with 
the specific dephosphorylation of the PDGF receptor in 
vivo, point to a direct action of this cytosolic PTPase on 
a membrane substrate. 
Our results demonstrate that the overexpression of the 
low M, PTPase in NIH/3T3 fibroblasts produces a de- 
crease of cellular response to PDGF with regard to mito- 
genie activity and protein phosphorylation. Contrary to 
the findings of studies on other intracellular PTPases 
11 
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Fig. 4. Tyrosine phosphorylation pattern in control and low M, PTPase 
overexpressing NIH/3T3 under PDGF-BB stimulation in the presence 
of PTPase inhibitors. Immunoblot of tyrosine-phosphorylated proteins 
separated by SDS-PAGE. Cells were treated as in Fig. 3 except that the 
stimulation with 10 ng/ml of PDGF-BB was preceded by incubation for 
10 min with 2 mM vanadate and for 30 min with 20 PM PAO. Lanes 
14 = control NIH13T3; lanes 5-8: PTPase NIH13T3. Lanes 1 and 
5 = unstimulated; lanes 2 and 6 = unstimulated, treated with PA0 and 
vanadate; lanes 3 and 7 = 10 ng/ml PDGF; lanes 4 and 8 = 10 ng/ml 
PDGF, treated with PA0 and vanadate. 
[34], this enzyme, a cytosolic low 1M, PTPase, not only 
inhibits cell proliferation but also affects tyrosine auto- 
phosphorylation of a transmembrane kinase, the PDGF 
receptor. The interaction between the PTPase and the 
receptor does not proceed by src homology domains and 
the enzyme is not phosphorylated by the receptor kinase 
activity. Cellular compartmentalization as a major factor 
in defining activity and function seems to be a rather 
necessary limitation to particulate enzymes but not to 
soluble ones. The capability of the low M, PTPase for 
dephosphorylating the autophosphorylated EGF recep- 
tor in vitro paves the way for a possible action on other 
phosphorylated receptors that will be the object of fur- 
ther investigations. In conclusion, the study of this en- 
zyme, and in general of PTPases, could offer new possi- 
bilities in the understanding of the role of PTPases as a 
crucial part of signal transduction. 
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